Prednisolone Acetate Eye Drop Recall Lawsuit: Over 2.5 Million Bottles of Prednisolone Acetate Eye Drop Recalled Nationwide Due to Foreign Substance Contamination

What Parker Waichman LLP Found

• More than 2.5 million bottles of prednisolone acetate eye drops were recalled nationwide.
• The FDA stated the recall was initiated because of the presence of a foreign substance in the medication.
• The recalled products were manufactured by Lupin Limited and distributed throughout the United States.
• The FDA classified the action as a Class II recall, indicating the potential for temporary or medically reversible health consequences.
• Patients who suffered eye injuries or complications may have legal options depending on the circumstances of their case.

Millions of patients rely on prescription eye medications every year to treat inflammation, allergic reactions, and other eye conditions that can affect vision and quality of life. When patients receive a prescription from a physician and pick up medication from a pharmacy, they trust that the product has been manufactured under strict quality-control standards and is safe to use as directed. A recent nationwide recall involving more than 2.5 million bottles of prednisolone acetate ophthalmic suspension has raised significant concerns about whether those expectations were met.

According to information released by the U.S. Food and Drug Administration (FDA), approximately 2,530,182 bottles of Prednisolone Acetate Ophthalmic Suspension, USP, 1% were recalled because of the reported presence of a foreign substance in the product. The recalled eye drops were manufactured by Lupin Limited, a pharmaceutical company headquartered in India, and distributed throughout the United States.

The FDA initially reported the recall on June 4 and later classified it as a Class II recall on June 30. A Class II recall indicates that use of the affected product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is considered remote. Even though the FDA’s classification does not indicate the highest level of danger, contamination involving a product intended to be placed directly into the eye presents serious concerns for patients and healthcare providers.

For consumers who used recalled eye drops and later experienced eye irritation, inflammation, infection, vision complications, or other injuries, the recall may raise important questions regarding liability, patient safety, and legal rights.

Understanding Prednisolone Acetate Eye Drops and Their Medical Uses

Prednisolone acetate ophthalmic suspension is a prescription corticosteroid medication commonly prescribed to reduce inflammation inside and around the eye. Physicians frequently recommend these eye drops following eye surgery, eye injuries, allergic reactions, or inflammatory eye conditions.

Inflammation affecting the eye can cause pain, redness, swelling, blurred vision, sensitivity to light, and discomfort. Corticosteroid eye drops help reduce the body’s inflammatory response and can play an important role in preserving vision and promoting healing.

Because these medications are placed directly into the eye, manufacturers are expected to maintain exceptionally high standards of cleanliness and sterility during production. Even a small amount of contamination can create potential risks because the eye is highly sensitive and vulnerable to injury.

Unlike many oral medications that must pass through the digestive system, ophthalmic drugs are applied directly to delicate ocular tissues. As a result, manufacturing errors, contamination, or foreign material present in the solution may expose patients to unique risks that can affect both short-term and long-term eye health.

When contamination concerns lead to a recall involving millions of bottles, regulators, healthcare providers, and consumers understandably seek answers regarding how the problem occurred and whether injuries may have resulted.

Why the Presence of a Foreign Substance Is a Serious Concern

The FDA stated that the recall was initiated because of the presence of a foreign substance within the affected eye drop products. Although public announcements do not always immediately identify the exact nature of the contaminant, the existence of foreign material inside a sterile ophthalmic medication can create substantial safety concerns.

Patients expect prescription eye drops to be free from contaminants, particles, manufacturing debris, and other foreign matter. Any unexpected substance introduced into the eye can potentially lead to complications.

Depending on the nature of the contamination, patients may face risks such as:

• Eye irritation
• Inflammation
• Corneal injury
• Scratches to ocular tissues
• Infection
• Allergic reactions
• Blurred vision
• Temporary vision impairment
• Increased eye pain
• Additional medical treatment

In some situations, contamination may require emergency medical evaluation, particularly if symptoms worsen after medication use.

Individuals who recently used prednisolone acetate eye drops and experienced unusual symptoms should consult healthcare providers promptly. Eye-related complications can worsen quickly if left untreated.

The Scope of the Recall Is Unusually Large

One aspect that has attracted attention is the enormous size of the recall. More than 2.5 million bottles were affected, making this one of the larger pharmaceutical recalls involving ophthalmic medications in recent years.

The recall includes:

• 5-mL bottles
• 10-mL bottles
• 15-mL bottles

The affected products carry National Drug Codes:

• NDC 70748-332-02
• NDC 70748-332-03
• NDC 70748-332-04

The recall encompasses numerous lot numbers and expiration dates extending into 2028.

The size of the recall suggests that contaminated products may have remained within the distribution chain for an extended period before the issue was identified. When millions of units are involved, patients across multiple states may have received affected medications through pharmacies, healthcare providers, hospitals, surgical centers, and other medical facilities.

Large-scale recalls often trigger investigations into manufacturing procedures, quality-control protocols, inspection practices, and regulatory compliance measures.

Potential Injuries Associated With Contaminated Ophthalmic Medications

Not every patient who uses a recalled medication will suffer an injury. However, contaminated ophthalmic products can create risks that may require medical attention.

Potential complications associated with contaminated eye drops may include:

Eye Inflammation and Irritation

Foreign material introduced into the eye can trigger redness, burning, itching, discomfort, swelling, and increased sensitivity.

Corneal Damage

Particles or contaminants may scratch or damage the cornea. Corneal injuries can affect vision and may require additional treatment.

Eye Infections

Contamination involving microorganisms can potentially lead to bacterial or fungal infections. Eye infections can become serious if not diagnosed and treated promptly.

Vision Problems

Patients may experience blurred vision, visual disturbances, sensitivity to light, or other symptoms requiring evaluation by an eye care professional.

Additional Medical Procedures

Some patients may require additional examinations, prescription medications, specialist visits, or corrective treatment to address complications resulting from contaminated products.

For individuals who underwent eye surgery or were being treated for existing eye conditions, contamination-related complications may be especially concerning because these patients may already have vulnerable ocular tissues.

Understanding Product Liability Claims Involving Recalled Medications

Pharmaceutical recalls often lead consumers to ask whether legal claims may be available if injuries occurred.

Product liability laws exist to hold manufacturers accountable when dangerous or defective products enter the marketplace. Drug-related lawsuits may involve several legal theories depending on the circumstances.

Manufacturing Defects

Manufacturing defect claims focus on whether errors occurred during production that caused contamination, impurities, or unsafe conditions within the product.

Negligence

A negligence claim may examine whether a manufacturer acted reasonably in producing, testing, monitoring, and distributing medications.

Failure to Warn

In certain situations, litigation may examine whether sufficient warnings were provided once contamination concerns became known.

Breach of Consumer Safety Obligations

Manufacturers that place contaminated pharmaceutical products into commerce may face allegations that they failed to meet safety expectations consumers reasonably rely upon when using prescription medications.

Every potential claim depends on the specific facts, medical evidence, and circumstances surrounding the patient’s injuries.

What Patients Should Do If They Have Recalled Eye Drops

Patients who possess affected prednisolone acetate eye drops should carefully compare their medication with the FDA recall information, including the National Drug Code, lot number, and expiration date.

Consumers should not make independent decisions about stopping prescription treatment without medical guidance. The FDA advises patients to consult healthcare providers or pharmacists regarding appropriate next steps.

Patients should consider:

• Checking the bottle’s NDC number
• Reviewing lot information
• Contacting their pharmacist
• Consulting the prescribing physician
• Monitoring for unusual symptoms
• Seeking prompt medical attention if eye problems develop

Individuals who believe they suffered complications should preserve medication packaging, pharmacy records, receipts, medical records, and photographs of symptoms whenever possible.

These materials may later help establish whether recalled medication was involved.

Eye Drop Injury Lawsuit FAQs

Can I file a lawsuit if I used recalled prednisolone acetate eye drops?

Possibly. If you used recalled eye drops and later experienced eye injuries, infections, vision problems, or other complications, you may have grounds to pursue a product liability claim. An investigation would typically examine whether the recalled medication contributed to your injuries and whether damages resulted from the contamination.

What injuries may support a claim involving contaminated eye drops?

Potential claims may involve eye irritation, inflammation, infections, corneal injuries, worsening vision, additional medical procedures, or other documented complications connected to the recalled medication. Medical records often play an important role in determining whether a claim exists.

Does a recall automatically mean I am entitled to compensation?

No. A recall alone does not automatically create a lawsuit. However, a recall can serve as evidence that a product may have contained a defect or contamination issue. Compensation generally depends on whether the consumer suffered actual injuries or losses connected to the recalled product.

What evidence should I keep if I believe I was harmed?

Patients should preserve the medication bottle, packaging, pharmacy records, prescription information, receipts, photographs, and medical records. Documentation showing the lot number and NDC number may be particularly important.

Who may be responsible for injuries caused by contaminated medications?

Depending on the facts, potentially responsible parties may include manufacturers, distributors, suppliers, and other entities involved in producing and distributing the medication. Determining liability often requires a detailed investigation.

What compensation may be available in a recalled drug case?

Compensation may include medical expenses, future treatment costs, lost wages, pain and suffering, emotional distress, and other damages associated with the injury. The available compensation depends on the severity of the injury and the circumstances of the case.

How long do I have to file a recalled medication lawsuit?

Filing deadlines vary by state and by the specific facts of the case. Because legal time limits can affect your rights, individuals who believe they were harmed by a recalled medication should investigate potential claims as soon as possible.

Injured After Using Recalled Prednisolone Acetate Eye Drops? Contact Parker Waichman LLP For A Consultation

Prescription medications should help patients heal, not expose them to unnecessary risks. If you used recalled prednisolone acetate eye drops and later experienced eye injuries, infections, vision complications, or other adverse effects, you may have important legal rights.

Parker Waichman LLP represents individuals nationwide in litigation involving recalled medications, pharmaceutical defects, contaminated medical products, and serious injuries caused by unsafe consumer products.

The firm offers free consultations to help determine whether you may be entitled to compensation for your injuries and losses.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free case evaluation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.